Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Bayer donates three million malaria tablets to U.S. for potential use against coronavirus

FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

Bayer AG said on Thursday it has donated 3 million tablets of the malaria drug Resochin to the U.S. government for potential use to treat COVID-19.

Resochin, made of chloroquine phosphate and an approved treatment for malaria, is being evaluated in China for its potential use against COVID-19, the disease caused by the fast-spreading coronavirus.

Bayer said the drug is currently not approved for use in the United States and the company is working with appropriate agencies on an emergency use authorization for its use in the United States.

U.S. President Donald Trump, speaking at a news conference on Thursday, called on U.S. health regulators to expedite potential therapies such as Gilead Sciences Inc's Remdesivir and the generic antimalarial drug hydroxychloroquine, aimed at treating COVID-19.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.